aTyr Pharma reported $79.65M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Ardelyx USD 504.51M 2.9M Mar/2026
aTyr Pharma USD 79.65M 435.68M Mar/2026
Biogen USD 32.09B 2.6B Jun/2026
Bristol-Myers Squibb USD 87.63B 1.16B Jun/2026
Cipla INR 424.96B 23.32B Mar/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 145.86M 10.71M Mar/2026
CSL USD 37.9B 1.5B Dec/2025
Curis USD 29.69M 9.72M Mar/2026
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
Grifols EUR 23.15B 142.7M Dec/2025
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Novartis USD 122.03B 3.5B Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
United Therapeutics USD 7.22B 505.9M Jun/2026